Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-To-Treat Relapsed/Refractory Multiple Myeloma

AuthID
P-00W-YQH
11
Author(s)
He, JM
·
Berringer, H
·
Ruan, HY
·
Johnston, S
·
Mendes, J
·
Lam, A
·
Mackay, E
Tipo de Documento
Article
Year published
2022
Publicado
in ADVANCES IN THERAPY, ISSN: 0741-238X
Volume: 39, Número: 9, Páginas: 4230-4249 (20)
Indexing
Publication Identifiers
Pubmed: 35876974
SCOPUS: 2-s2.0-85134783240
Wos: WOS:000829753400001
Source Identifiers
ISSN: 0741-238X
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.